首页> 外国专利> p65 A Novel Fusion Protein Comprising Transcription Modulation Domain of p65 and Protein Transduction Domain and Uses Thereof

p65 A Novel Fusion Protein Comprising Transcription Modulation Domain of p65 and Protein Transduction Domain and Uses Thereof

机译:p65包含转录调控域p65和蛋白转导域的新型融合蛋白及其用途

摘要

The present invention relates to novel fusion proteins comprising the transcriptional and regulatory domains of p65, a subunit of the transcription factor NF-kB, and their use. According to the present invention, the fusion protein of the present invention suppresses the transcription of NF-κB and IL-2 by competitive inhibition, inhibits the secretion of inflammatory cytokines by LPS, inhibits IL-2, IFN- gamma], IL-4, IL-17A and IL-10, and may be useful as a composition for the prophylaxis or treatment of NF-κB and activity-related diseases.
机译:本发明涉及新颖的融合蛋白,其包含p65的转录和调节域,转录因子NF-kB的亚基及其用途。根据本发明,本发明的融合蛋白通过竞争性抑制来抑制NF-κB和IL-2的转录,通过LPS抑制炎性细胞因子的分泌,抑制IL-2,IFN-γ,IL-4 ,IL-17A和IL-10,并且可用作预防或治疗NF-κB和与活动有关的疾病的组合物。

著录项

  • 公开/公告号KR101889140B1

    专利类型

  • 公开/公告日2018-08-17

    原文格式PDF

  • 申请/专利权人 연세대학교 산학협력단;

    申请/专利号KR20150142144

  • 发明设计人 이상규;박성동;

    申请日2015-10-12

  • 分类号C07K14/47;A61K38/17;A61K47/48;

  • 国家 KR

  • 入库时间 2022-08-21 12:37:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号